GERALD FITZGERALD: Open Payments
NPI 1508050196 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 27 payments from 14 companies in 2025. Trend: 2023 $614 · 2024 $825 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| ABBVIE INC. | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| PFIZER INC. | 2 | $33 |
| Dexcom, Inc. | 2 | $33 |
| Renalytix AI, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: XIFAXAN, AIRSUPRA, CAPLYTA, TRELEGY ELLIPTA, LEQVIO, QULIPTA, NURTEC ODT, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
